Companion Animal Speciality Drugs Market

In a new publication titled “Companion Animal Speciality Drugs Market: Global Industry Analysis and Opportunity Assessment 2017-2027,” Future Market Insights leverages the Porters Five Forces Model to present insightful research findings on the performance of the global companion animal speciality drugs market over a 10 year forecast period 2017 – 2027. According to the report, the popularity of generic drugs is increasing in the companion animal market, and thus can be a potential threat to branded prescription equivalents, which are highly matured products. After applying the Porters Five Forces Model to examine this market, we have observed that fluctuations in pathogenesis and outbreak patterns of diseases and fluctuating supply of companion/production animal products in the market is expected to lower bargaining power of buyers. Furthermore, our analysts have arrived at a conclusion that there is medium level threat by the entry of generic drug manufacturers and compound pharmacies. There can also be influx of start-up research enterprises through government support for biotechnology/research. Our research also suggests that the market for anti-obesity prescription drugs usage in pets is limited to North America and marginally in Australia. For all other regions these drugs have unauthorised/off-label usage. We have observed the following traits while inspecting the global companion animal speciality drugs market:

• Increasing distribution channels in emerging economies by established Western players is likely to create differences in revenue generation

• Product and process innovation assessed in terms of reinvestment of profits to R&D expenses is anticipated to create major differences in market approach by key players

• Increased demand for parasiticides is expected to contribute the most towards future revenue growth

• Branded drugs are much preferred over generics and compounded companion animal drugs

• Parasiticides and vaccines are the key segments by product accounting for the largest revenue generation

• Branded drugs are much preferred over generics and compounded companion animal drugs

• Increased demand for parasiticides is expected to contribute the most towards future revenue growth

Report Structure

We have covered the various market segments extensively while examining the global companion animal speciality drugs market and have touched all the aspects of the different sub-segments. Market analysis has been done in terms of Basis Point Share, and Y-o-Y growth projections have also been covered for every segment. This extensive report focusses on highlighting sales of companion animal speciality drugs across the globe. Macro-economic indicators such as adoption of pets, number of pets by country and availability of veterinary clinics have been considered to arrive at the indicated market numbers. For Anti-Obesity drugs, product dossiers have been considered and market numbers have been derived from primary research as most drugs are being used in an unauthorised manner. Top-down approach has been used to counter-validate the reached numbers for the global companion animal speciality drugs market. Parent company financial statements have been analysed to track margins. We have collected this insightful information through sources such as annual reports, publications and companion animal speciality drugs manufacturer presentations. Veterinary journals, product dossiers, government websites, NCBI and case reports have also been referred to while studying this market.

Market Segmentation

Research Methodology

We have used in-depth secondary research to ascertain the overall market size, top industry players, products and industry associations. In order to conduct expert and industry interviews, Future Market Insights has formulated a detailed discussion guide. Our analysts have conducted interviews with industry experts, players, distributors and retailers. The forecast presented in the report assesses the total revenue of the global companion animal speciality drugs market. When developing the market forecast, the starting point involves sizing the current market, which forms the basis for the forecast of how the market is anticipated to take shape in the near future. Given the characteristics of the market, we have triangulated the outcome on the basis of analysis based on supply and demand sides. The report also takes into consideration year-on-year growth to understand the predictability of the market and to identify the right opportunities across the global companion animal speciality drugs market. As previously highlighted, the market for global companion animal speciality drugs is split into various segments. All these segments have been analysed in terms of basis point share to understand each individual segment’s relative contribution to overall market growth. This detailed level of information is important for identifying the various key trends in the global companion animal speciality drugs market.